nad has been researched along with Vascular Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curran, CS; Kopp, JB | 1 |
| Balasubramanian, P; Baur, JA; Csiszar, A; Farkas, E; Kiss, T; Tarantini, S; Ungvari, Z; Yabluchanskiy, A | 1 |
| AGUSTINARZENO, J; DEFERNANDEZBLANCO, JF; FERNANDEZBLANCO, E | 1 |
| Dobrucki, IT; Kalinowski, L; Malinski, T | 1 |
| Janiszewski, M; Laurindo, FR; Liu, X; Pedro, MA; Souza, HP; Zweier, JL | 1 |
2 review(s) available for nad and Vascular Diseases
| Article | Year |
|---|---|
The complexity of nicotinamide adenine dinucleotide (NAD), hypoxic, and aryl hydrocarbon receptor cell signaling in chronic kidney disease.
Topics: Basic Helix-Loop-Helix Transcription Factors; Humans; Hypoxia; Ischemia; NAD; Niacin; Receptors, Aryl Hydrocarbon; Renal Insufficiency, Chronic; Signal Transduction; Vascular Diseases | 2023 |
Role of endothelial NAD
Topics: Age Factors; Aging; Animals; Cellular Senescence; Endothelium, Vascular; Energy Metabolism; Humans; NAD; Oxidative Stress; Signal Transduction; Vascular Diseases | 2019 |
3 other study(ies) available for nad and Vascular Diseases
| Article | Year |
|---|---|
[7-(3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL)-1, 3-DIMETHYL-XANTHINE NICOTINATE IN CHRONIC OBLITERATING ANGIOPATHIES].
Topics: Arteriosclerosis; Arteriosclerosis Obliterans; Cholesterol; Coronary Disease; Humans; Intracranial Arteriosclerosis; Lipid Metabolism; NAD; Niacin; Nicotinic Acids; Pharmacology; Theophylline; Toxicology; Vascular Diseases; Vasodilator Agents; Vasomotor System; Xanthine | 1963 |
Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases.
Topics: Acetophenones; Adult; Benzopyrans; Black or African American; Cells, Cultured; Disease Susceptibility; Endothelial Cells; Endothelium, Vascular; Female; Humans; Meclofenamic Acid; NAD; NADP; NADPH Oxidases; Nanotechnology; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidation-Reduction; Oxidative Stress; Oxypurinol; Peroxynitrous Acid; Phosphoproteins; Rotenone; Superoxides; Umbilical Veins; Vascular Diseases; White People | 2004 |
Overestimation of NADH-driven vascular oxidase activity due to lucigenin artifacts.
Topics: Acridines; Animals; Artifacts; Carotid Arteries; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Iliac Artery; Luminescent Measurements; Male; NAD; NADP; NADPH Oxidases; Oxidation-Reduction; Oxygen Consumption; Rabbits; Spin Labels; Vascular Diseases | 2002 |